SP-420
SP-420: a Fe modulators Drug, Initially developed by University of Florida, Now, its global highest R&D status is Phase 2, Mechanism: Fe modulators, Therapeutic Areas: Congenital Disorders,Hemic and Lymphatic Diseases,Other Diseases, Active Indication: Beta-Thalassemia,Transfusion-dependent Thalassemia,Reperfusion Injury, Active Org.: …